HOOK - Hookipa Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HOOK is currently covered by 5 analysts with an average price target of $18.82. This is a potential upside of $17.96 (2088.37%) from yesterday's end of day stock price of $0.86.

Hookipa Pharma's activity chart (see below) currently has 25 price targets and 33 ratings on display. The stock rating distribution of HOOK is 84.62% BUY and 15.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 30.95% with an average time for these price targets to be met of 235 days.

Highest price target for HOOK is $2, Lowest price target is $2, average price target is $2.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 20-Dec-2024. First documented stock forecast 13-May-2019.

Currently out of the existing stock ratings of HOOK, 11 are a BUY (84.62%), 2 are a HOLD (15.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$2

$0.86 (75.44%)

11 months 16 days ago
(20-Dec-2024)

1/6 (16.67%)

$-0.02 (-0.99%)

4

Buy

$7

$5.86 (514.04%)

$23

1 years 15 days ago
(21-Nov-2024)

2/4 (50%)

$4.7 (204.35%)

381

Buy

$23

$21.86 (1917.54%)

$11

1 years 4 months 10 days ago
(26-Jul-2024)

1/2 (50%)

$16.85 (273.98%)

375

Buy

$80

2 years 3 months 25 days ago
(11-Aug-2023)

0/2 (0%)

$60 (300.00%)

Hold

$22.5

$21.36 (1873.68%)

$60

2 years 6 months 1 days ago
(05-Jun-2023)

2/4 (50%)

$10.9 (93.97%)

98

Show more analysts

Please expand the browser size to see the chart

What is HOOK (Hookipa Pharma) average time for price targets to be met?

On average it took 235 days on average for the stock forecasts to be realized with a an average price target met ratio 30.95

Which analyst has the current highest performing score on HOOK (Hookipa Pharma) with a proven track record?

ROY BUCHANAN

Which analyst has the current lower performing score on HOOK (Hookipa Pharma) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on HOOK (Hookipa Pharma)?

Roy Buchanan works at JMP and has 2 price targets and 1 ratings on HOOK

Which analyst is the currently most bullish on HOOK (Hookipa Pharma)?

Asthika Goonewardene with highest potential upside - $38.86

Which analyst is the currently most reserved on HOOK (Hookipa Pharma)?

Andrew Berens with lowest potential downside - -$2.23

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?